株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自動乳房超音波検査システム(ABUS)の世界市場:2019年~2023年

Global Automated Breast Ultrasound Systems(ABUS) Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 825221
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
自動乳房超音波検査システム(ABUS)の世界市場:2019年~2023年 Global Automated Breast Ultrasound Systems(ABUS) Market 2019-2023
出版日: 2019年03月27日 ページ情報: 英文 117 Pages
概要

乳房画像診断における有効性の欠如および偽陽性生検を減少させる必要性から、メーカーは次世代および統合型ABUSを開発することによって製品範囲拡大に焦点を合わせています。エンドユーザーは専門治療を提供することに集中しています。その為、多くのエンドユーザーが診断ユニットに新しく発売されたABUSをインストールしています。 ABUSの発売およびABUS用の統合ツールの増加により、予測期間中に市場の成長が促進される見込みです。 Technavioのアナリストは、世界の自動乳房超音波検査システム(ABUS)市場が2023年までに14%以上のCAGRで成長すると予測しています。

当レポートでは、世界の自動乳房超音波検査システム(ABUS)市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション:エンドユーザー別
  • エンドユーザー別比較:市場規模および予測(2018年~2023年)
  • 病院・診療所
  • 診断センター
  • 市場機会:エンドユーザー別

第7章 顧客情勢

第8章 地域情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • その他の地域
  • アジア
  • 主要国
  • 市場機会

第9章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第10章 市場動向

  • ABUS開発のための資金と設備投資
  • 乳房画像撮影製品の講座と医療展示会への注目の高まり
  • 革新的な統合型ABUSの開発へ集まる注目

第11章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競合シナリオ

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • GE Healthcare
  • 日立製作所
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • SonoCine

第13章 付録

  • 調査方法
  • 略語のリスト

第14章 TECHNAVIOについて

図表
  • Exhibit 01: Global medical imaging market
  • Exhibit 02: Segments of global medical imaging market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Hospitals and clinics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hospitals and clinics - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Diagnostic centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Diagnostic centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by end-user
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Key leading countries
  • Exhibit 36: Market opportunity
  • Exhibit 37: Breast cancer cases in US states
  • Exhibit 38: ABUS launches by companies and market impact analysis
  • Exhibit 39: Product recalls: Overview
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: GE Healthcare - Vendor overview
  • Exhibit 47: GE Healthcare - Business segments
  • Exhibit 48: GE Healthcare - Organizational developments
  • Exhibit 49: GE Healthcare - Geographic focus
  • Exhibit 50: GE Healthcare - Segment focus
  • Exhibit 51: GE Healthcare - Key offerings
  • Exhibit 52: GE Healthcare - Key customers
  • Exhibit 53: Hitachi, Ltd. - Vendor overview
  • Exhibit 54: Hitachi, Ltd. - Product segments
  • Exhibit 55: Hitachi, Ltd. - Organizational developments
  • Exhibit 56: Hitachi, Ltd. - Geographic focus
  • Exhibit 57: Hitachi, Ltd. - Segment focus
  • Exhibit 58: Hitachi, Ltd. - Key offerings
  • Exhibit 59: Hitachi, Ltd. - Key customers
  • Exhibit 60: Koninklijke Philips N.V. - Vendor overview
  • Exhibit 61: Koninklijke Philips N.V. - Business segments
  • Exhibit 62: Koninklijke Philips N.V. - Organizational developments
  • Exhibit 63: Koninklijke Philips N.V. - Geographic focus
  • Exhibit 64: Koninklijke Philips N.V. - Segment focus
  • Exhibit 65: Koninklijke Philips N.V. - Key offerings
  • Exhibit 66: Koninklijke Philips N.V. - Key customers
  • Exhibit 67: Siemens Healthineers AG - Vendor overview
  • Exhibit 68: Siemens Healthineers AG - Business segments
  • Exhibit 69: Siemens Healthineers AG - Organizational developments
  • Exhibit 70: Siemens Healthineers AG - Geographic focus
  • Exhibit 71: Siemens Healthineers AG - Segment focus
  • Exhibit 72: Siemens Healthineers AG - Key offerings
  • Exhibit 73: Siemens Healthineers AG - Key customers
  • Exhibit 74: SonoCine - Vendor overview
  • Exhibit 75: SonoCine - Organizational developments
  • Exhibit 76: SonoCine - Key offerings
  • Exhibit 77: SonoCine - Key customers
  • Exhibit 78: Validation techniques employed for market sizing
目次
Product Code: IRTNTR31086

About this market

The lack of efficacy in breast diagnostic imaging and the need to reduce false-positive biopsies are leading companies to focus on product range expansion by developing next-generation and integrated ABUS. End-users are focusing on providing specialized care and treatment. Hence, many end-users are installing newly launched ABUS in their diagnostic units. The increasing number of ABUS launches and integrated tools for ABUS will drive market growth during the forecast period. Technavio's analysts have predicted that the automated breast ultrasound systems (ABUS) market will register a CAGR of more than 14% by 2023.

Market Overview

Increasing demand for breast imaging products owing to growing prevalence of breast cancer cases

The growing number of breast cancer cases is boosting the demand for ABUS. Factors such as increasing age, a family history of breast cancer, radiation exposure, and post-menopausal hormone therapy can lead to breast cancer. Oncologists prefer using breast imaging products such as ABUS due to their efficacy in diagnostic results. With the growing number of breast cancer cases globally, the need for ABUS increases, thereby boosting market growth.

Product recall of ABUS due to labeling and design issues

End-users rely on companies that provide high-quality products, which can provide efficacious results. However, if any product enters the market with a deformity, it is either recalled by the firm that has developed it or regulatory bodies such as the US FDA and the Therapeutic Goods Administration (TGA). Product recalls can affect the brand image of the company and can lead to a reduction in sales revenue.

For the detailed list of factors that will drive and challenge the growth of the automated breast ultrasound systems (ABUS) market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and clinics - Market size and forecast 2018-2023
  • Diagnostic centers - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Funding and capital investments for the development of ABUS
  • Growing focus on courses and medical exhibition for breast imaging products
  • Growing focus on development of integrated and innovative ABUS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • GE Healthcare
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • SonoCine

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

PART 14: EXPLORE TECHNAVIO

Back to Top